Discover

NVO
Novo Nordisk A/S
48.77
3400 x undefined
900 x undefined
bid
ask
+
0.83
1.73%
2150 @ 06:34 AM
49.18 +0.41 (0.84%)
Ytd-4.15%
1y-30.15%
48.61
day range
49.55
35.12
52 week range
71.80
Open49.02Prev Close47.94Low48.61High49.55Mkt Cap215.85B
Vol11.03MAvg Vol14.91MEPS4.16P/E11.72Forward P/E14.85
Beta0.35Short Ratio1.84Inst. Own9.81%Dividend1.80Div Yield3.73
Ex Div Date03-30Earning08-0550-d Avg44.26200-d Avg47.861yr Est47.53

NVO News

Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note
zacks.com
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note

In the latest trading session, Novo Nordisk (NVO) closed at $48.77, marking a +1.73% move from the p

Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage
zacks.com
Weight Loss ETFs Poised to Rally as Medicare Greenlights GLP-1 Coverage

Medicare's new GLP-1 coverage could expand access to weight-loss drugs, making ETFs a diversified wa

AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity
247wallst.com
AI Is Transforming Drug Discovery. Here Is the Next Trillion-Dollar Biotech Opportunity

Artificial intelligence is reshaping nearly every industry, but some of its biggest opportunities ar

Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday
benzinga.com
Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls

Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility a

Medicare will start covering obesity drugs for the first time. Here's what patients should know
cnbc.com
Medicare will start covering obesity drugs for the first time. Here's what patients should know

Starting Wednesday, eligible seniors with Medicare coverage can access GLP-1s for obesity with a cop

Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?
zacks.com
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?

NVO and VKTX stocks offer contrasting opportunities in the fast-growing obesity market, with key dif

Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Novo Nordisk (NVO). This makes it wort

Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up
proactiveinvestors.co.uk
Citi says Wegovy pill outpacing rivals as oral GLP-1 race heats up

Citi has said Novo Nordisk's (NYSE:NVO) Wegovy pill is outpacing its rivals in the United States, ev

My Top 10 High-Yield Picks For July 2026: One Yields More Than 13%
seekingalpha.com
My Top 10 High-Yield Picks For July 2026: One Yields More Than 13%

I present my top 10 high-yield dividend stocks for July 2026, emphasizing margin of safety, attracti

Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet
cnbc.com
Seniors in Medicare are about to get landmark obesity drug coverage — but many may not know it yet

Millions of older Americans in Medicare are about to gain access to obesity drugs through Medicare's

4 Health Care Stocks With Whale Alerts In Today’s Session
benzinga.com
4 Health Care Stocks With Whale Alerts In Today’s Session

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?
fool.com
An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference

Novo Nordisk is no longer the front-runner, but it's not out of the running, either.

benzinga.com
Eli Lilly Announces Additional Details On Medicare GLP-1 Bridge Program From July 1; Medicare Part D

The Medicare GLP-1 Bridge program will be the first time eligible Medicare Part D patients will be a

Novo's top US exec wants more insurance coverage for weight-loss drugs
reuters.com
Novo's top US exec wants more insurance coverage for weight-loss drugs

Denmark's Novo Nordisk , the maker of weight-loss drug Wegovy, hopes insurance will cover more U.S.

White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The President'
benzinga.com
White House Denies Report Linking Trump To Eli Lilly's Experimental Obesity Treatment: 'Not For The

White House denies reports Trump received Eli Lilly's unapproved obesity drug retatrutide throug

Novo Nordisk Stock Is Surging Monday: What's Driving The Action?
benzinga.com
Novo Nordisk Stock Is Surging Monday: What's Driving The Action?

Novo-Nordisk shares are trading higher by more than 6% on Monday as GLP‑1 support initiatives aimed

benzinga.com
CVS Pharmacy Announces New GLP-1 Offerings, Including Expanded Pharmacy Support And A New $49 Minute

As demand for GLP-1 medications continues to increase across the U.S., CVS Health® (NYSE:CVS) today

Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model
benzinga.com
Less Volume, More Premium: Post-Ozempic Economics Are Killing The Quantity Model

As millions take GLP-1 drugs, packaged food giants face declining volumes while protein brands and s

Hims & Hers Stock Jumps After Barclays Raises Price Target
benzinga.com
Hims & Hers Stock Jumps After Barclays Raises Price Target

Hims & Hers Health (NYSE: HIMS) shares are climbing after Barclays reiterated its bullish stance

Novo Nordisk Data Breach: Hackers Claim To Have Stolen Drug Research, Trial Data And AI Models
benzinga.com
Novo Nordisk Data Breach: Hackers Claim To Have Stolen Drug Research, Trial Data And AI Models

Novo Nordisk investigates claims by cyber group FulcrumSec alleging a 1.3TB data theft after a faile

7 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
7 Health Care Stocks With Whale Alerts In Today's Session

benzinga.com
Reported June 16, 2026: 'Hacking Group Claims Major Hack Of Novo Nordisk And Attempted $25 Million E

https://www.reuters.com/legal/government/hacking-group-claims-major-hack-novo-nordisk-attempted-25-m

benzinga.com
Reported Earlier: 'Novo Nordisk to seek approval soon to sell Wegovy pill in China' - Reuters

https://www.reuters.com/world/novo-nordisk-seek-regulatory-approval-wegovy-pill-china-soon-says-ceo-

Doctors Warn Medicare's New Weight-Loss Drug Program Could Lead To A Rush Of Patients That Clinics May Struggle To Handle
benzinga.com
Doctors Warn Medicare's New Weight-Loss Drug Program Could Lead To A Rush Of Patients That Clinics M

Medicare's GLP-1 rollout could overwhelm doctors as seniors rush for $50 weight-loss drugs.

Novo Nordisk Advances Weight-Loss Portfolio With UK Approval Of Wegovy Tablet
benzinga.com
Novo Nordisk Advances Weight-Loss Portfolio With UK Approval Of Wegovy Tablet

Novo Nordisk wins U.K. approval for Wegovy pill, offering adults a daily oral weight-loss option bac

benzinga.com
Novo Nordisk Reports Unauthorized Access IT Security Incident; Core Business Operations Are Not Impa

https://www.novonordisk.com/content/nncorp/global/en/news-and-media/news-and-ir-materials/news-detai

benzinga.com
Wegovy Receives Medicines And Healthcare Products Regulatory Agency's Approval To Treat Obesity

https://ml-eu.globenewswire.com/Resource/Download/eb763000-5b1f-4433-9713-f86ae3f76643

Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs
benzinga.com
Novo Nordisk Highlights Positive Weight-Loss Data Across Multiple Programs

Novo Nordisk reported positive diabetes and weight-loss data, advanced zenagamtide plans, and topped

Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'
benzinga.com
Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game

Novo Nordisk exploring additional uses for obesity drug semaglutide, including potential for longevi

4 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com
4 Health Care Stocks With Whale Alerts In Today's Session

benzinga.com
Veru Strikes Clinical Supply Agreement With Novo Nordisk To Mull Combination Of Enobosarm With Wegov

https://www.sec.gov/ix?doc=/Archives/edgar/data/863894/000143774926019478/veru20260601_8k.htm

10 Health Care Stocks Whale Activity In Today's Session
benzinga.com
10 Health Care Stocks Whale Activity In Today's Session